Dexamethasone NDC 70771-1701

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1701Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1701Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1701-1	70771170101	100 TABLET in 1 BOTTLE (70771-1701-1)Marketed from Apr 15, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dexamethasone
Generic name (nonproprietary): dexamethasone
Active ingredients: Dexamethasone — 2 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216283
Marketing start: Apr 15, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 70771-1701_6a9c20d5-8b08-4b8e-b422-705383158851SPL ID 6a9c20d5-8b08-4b8e-b422-705383158851SPL set ID 1e84a609-22a0-41b9-83a0-c45019c8cf9aRxCUI 197581UNII 7S5I7G3JQL
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771170101 followed by a unit qualifier and the quantity

Package 70771-1701-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 30, 2024.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216283

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216283
Product	Strength	Form · route	Labeler	Product NDC
Dexamethasone	Dexamethasone 2 mg/1	TabletOral	Viona Pharmaceuticals Inc	72578-167